Paul Tudor Jones's MRNA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 96,206 shares of Moderna, Inc. (MRNA) worth $2.84 M, representing 0.01% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 219,273 shares. Largest reduction occurred in Q4 2025, reducing 248,345 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -248,345 | Reduce 72.08% | 96,206 | $29.49 |
| Q3 2025 | -191,114 | Reduce 35.68% | 344,551 | $25.83 |
| Q2 2025 | +219,273 | Add 69.30% | 535,665 | $27.59 |
| Q1 2025 | -37,473 | Reduce 10.59% | 316,392 | $28.35 |
| Q4 2024 | +200,767 | Add 131.14% | 353,865 | $41.58 |
| Q3 2024 | +28,763 | Add 23.13% | 153,098 | $66.83 |
| Q2 2024 | +124,335 | New Buy | 124,335 | $118.75 |
| Q1 2023 | -9,779 | Sold Out | 0 | $0.00 |
| Q4 2022 | -26,582 | Reduce 73.11% | 9,779 | $0.18 |
| Q3 2022 | +22,026 | Add 153.65% | 36,361 | $118.26 |
| Q2 2022 | +8,502 | Add 145.76% | 14,335 | $142.87 |
| Q1 2022 | -3,849 | Reduce 39.75% | 5,833 | $172.30 |
| Q4 2021 | -14,215 | Reduce 59.48% | 9,682 | $253.98 |
| Q3 2021 | +14,618 | Add 157.54% | 23,897 | $384.86 |
| Q2 2021 | -19,487 | Reduce 67.74% | 9,279 | $234.94 |
| Q1 2021 | +18,821 | Add 189.25% | 28,766 | $130.95 |
| Q4 2020 | +1,707 | Add 20.72% | 9,945 | $104.47 |
| Q3 2020 | +8,238 | New Buy | 8,238 | $70.77 |
Paul Tudor Jones's Moderna Investment FAQs
Paul Tudor Jones first purchased Moderna, Inc. (MRNA) in Q3 2020, acquiring 8,238 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Moderna, Inc. (MRNA) for 18 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Moderna, Inc. (MRNA) was in Q2 2025, adding 535,665 shares worth $14.78 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 96,206 shares of Moderna, Inc. (MRNA), valued at approximately $2.84 M.
As of the Q4 2025 filing, Moderna, Inc. (MRNA) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Moderna, Inc. (MRNA) was 535,665 shares, as reported at the end of Q2 2025.